2Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes, 2005, 54(6):1615-1625.
3Griendling KK, Fitzgerald GA. Oxidative stress and cardiovascular in- jury: Part I: basic mechanisms and in vivo monitoring of ROS [ J]. Circulation, 2003, 108 (16) :1912 - 1916.
4Gao L, Huang W, Li J. NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes[ J]. Mol Cell Biochem, 2013,382 ( 1 - 2 ) : 185 - 191.
5Xu X, Chen P, Zheng Q, et al. Effect of pioglitazone on diabetic ne- phropathy and expression of HIF - 1 alpha and VEGF in the renal tis- sues of type 2 diabetic rats[ J]. Diabetes Res Clin Pract, 2011,93 (1) :63 -69.
6Zhao C, Rajendran A, Dai Q, et al. A pyrazine - based fluorescence -enhancing ligand with a high selectivity for thymine in AP site - containing DNA duplexes[ J]. Anal Sci, 2008, 24 (6) :693 -695.
7Kwiecien S, Konturek P C, Sliwowski Z, et al. Interaction between selective cyclooxygenase inhibitors and capsaicin - sensitive afferent sensory nerves in pathogenesis of stress - induced gastric lesions. Role of oxidative stress [ J ]. J Physiol Pharmacol, 2012, 63 ( 2 ) : 143 - 151.
9Wilkinson C P,Ferris F R,Klein R E,et al.Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.Ophthalmology,2003,110(9): 1677-1682.
